Falnidamol

DB12966InvestigationalSmall molecule

Falnidamol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Formula / weight: C₁₈H₁₉ClFN₇ · 387.85 g/mol (avg)
Code names: BIBX-1382

Resolves to

Compound

Structure

InChIKeyFTFRZXFNZVCRSK-UHFFFAOYSA-NSMILESCN1CCC(CC1)NC1=NC=C2N=CN=C(NC3=CC=C(F)C(Cl)=C3)C2=N1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

558Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Falnidamol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.